Stockreport

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activ [Read more]